Differential effects of phenylbutazone and local anesthetics on nociception in the equine.

The study investigates the impacts of different pain relievers, namely procaine, mepivacaine, and phenylbutazone, on horses’ response to pain. The experiment shows that successive exposures to a painful stimulus can result in an increased pain threshold.

Research Design

In this study, the researchers examined the effects of three drugs on equine nociception or pain perception. Nociception was tested using two behavioral assays:

• The thermal evoked hoof withdrawal reflex: a measure of how quickly a horse would retract its forelimb when exposed to a heat stimulus.
• The skin twitch reflex: an evaluation of how the horse’s skin muscles contract in response to pain.

The pain perception threshold, defined as the time delay from the onset of thermal stimuli to the reflex withdrawal of the forelimb or contraction of cutaneous musculature, was recorded.

Observations and Findings

The local anesthetics procaine 2% and mepivacaine 2% were found to have effects on the hoof withdrawal reflex latency when administered directly, by inducing a block of the palmar and metacarpal nerves. The analgesic effects of these substances were notably different:

• Procaine-induced analgesia lasted 90 minutes.
• Mepivacaine-induced analgesia stretched to 210 minutes.

In contrast, phenylbutazone (7.3 mg/kg) showed no significant changes in pain thresholds over a 36-hour post-treatment period.

Significance of the Study

Surprisingly, the study found that even though phenylbutazone didn’t actively change the pain perception, the pain threshold increased over time with successive trials. This suggests that repeated exposure to pain stimuli can raise the nociceptive thresholds in horses.

In conclusion, these findings reveal that:

• Phenylbutazone does not affect normal cutaneous pain perception in horses.
• Regular presentation of painful stimuli can incrementally increase pain thresholds, implying a potential natural coping mechanism to repeated pain exposures.